Falcon Point Capital Has Trimmed Masonite International (DOOR) Position; Neville Rodie & Shaw Trimmed Its Johnson & Johnson (JNJ) Position

November 14, 2017 - By Marguerite Chambers

Neville Rodie & Shaw Inc decreased Johnson & Johnson (JNJ) stake by 4.35% reported in 2017Q2 SEC filing. Neville Rodie & Shaw Inc sold 12,031 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Neville Rodie & Shaw Inc holds 264,512 shares with $34.99M value, down from 276,543 last quarter. Johnson & Johnson now has $375.98 billion valuation. The stock rose 0.14% or $0.19 reaching $139.95. About 658,891 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since November 14, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Falcon Point Capital Llc decreased Masonite International Corp (DOOR) stake by 3.36% reported in 2017Q2 SEC filing. Falcon Point Capital Llc sold 4,788 shares as Masonite International Corp (DOOR)’s stock rose 9.33%. The Falcon Point Capital Llc holds 137,834 shares with $10.41 million value, down from 142,622 last quarter. Masonite International Corp now has $2.02B valuation. The stock rose 0.78% or $0.55 reaching $70.8. About 12,957 shares traded. Masonite International Corp (NYSE:DOOR) has risen 9.52% since November 14, 2016 and is uptrending. It has underperformed by 7.18% the S&P500.

Investors sentiment decreased to 0.83 in 2017 Q2. Its down 0.03, from 0.86 in 2017Q1. It dived, as 50 investors sold JNJ shares while 878 reduced holdings. 105 funds opened positions while 667 raised stakes. 1.73 billion shares or 0.03% less from 1.73 billion shares in 2017Q1 were reported. Eagleclaw Cap Managment Ltd Liability holds 0.83% or 10,694 shares. Woodstock has 2.52% invested in Johnson & Johnson (NYSE:JNJ) for 97,020 shares. 162,038 are held by Tukman Grossman Cap Mngmt. Macguire Cheswick & Tuttle Inv Counsel Ltd Liability Corporation accumulated 134,559 shares. Cullen Mgmt Lc invested in 636,670 shares. Mcrae Capital Management stated it has 28,877 shares. Jefferies Ltd holds 0.18% or 203,872 shares in its portfolio. London Of Virginia stated it has 5,684 shares or 0.01% of all its holdings. Cacti Asset Mgmt Limited Liability Company invested in 3.17% or 267,340 shares. Pure Advisors holds 0.11% or 3,167 shares in its portfolio. Old Republic, a Illinois-based fund reported 281,800 shares. Driehaus Capital Ltd Liability Co reported 4,129 shares or 0.02% of all its holdings. 3,425 were reported by Deltec Asset Management. Chickasaw Cap Management Limited Liability has invested 0.16% in Johnson & Johnson (NYSE:JNJ). Moreover, Virginia Retirement Et Al has 1.79% invested in Johnson & Johnson (NYSE:JNJ).

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 23. They expect $1.72 earnings per share, up 8.86% or $0.14 from last year’s $1.58 per share. JNJ’s profit will be $4.62B for 20.34 P/E if the $1.72 EPS becomes a reality. After $1.90 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 13 have Buy rating, 5 Sell and 5 Hold. Therefore 57% are positive. Johnson & Johnson had 83 analyst reports since August 7, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the stock with “Hold” rating in Wednesday, October 18 report. The firm earned “Buy” rating on Thursday, August 24 by Cowen & Co. The firm has “Equal-Weight” rating by Barclays Capital given on Tuesday, November 29. Wells Fargo upgraded the stock to “Buy” rating in Monday, October 9 report. The firm has “Sell” rating given on Friday, July 21 by Atlantic Securities. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) on Monday, July 10 with “Buy” rating. RBC Capital Markets maintained it with “Buy” rating and $147.0 target in Wednesday, October 18 report. As per Thursday, August 31, the company rating was maintained by UBS. The company was maintained on Wednesday, October 18 by Jefferies. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by BMO Capital Markets on Friday, June 2.

Investors sentiment increased to 1.24 in 2017 Q2. Its up 0.07, from 1.17 in 2017Q1. It improved, as 24 investors sold DOOR shares while 48 reduced holdings. 28 funds opened positions while 61 raised stakes. 28.28 million shares or 1.28% more from 27.92 million shares in 2017Q1 were reported. Bnp Paribas Arbitrage Sa, a New York-based fund reported 3,836 shares. Susquehanna Intl Llp reported 0% of its portfolio in Masonite International Corp (NYSE:DOOR). Rainier Invest Management Limited Liability Corp reported 0.3% in Masonite International Corp (NYSE:DOOR). Ameriprise Fincl Inc owns 61,396 shares for 0% of their portfolio. First Tru Advsr LP stated it has 0% in Masonite International Corp (NYSE:DOOR). Driehaus Cap Management Llc holds 0.07% of its portfolio in Masonite International Corp (NYSE:DOOR) for 24,086 shares. Great West Life Assurance Can reported 0% of its portfolio in Masonite International Corp (NYSE:DOOR). 9,909 were accumulated by Regions Fin. Ahl Prtnrs Ltd Liability Partnership holds 21,901 shares. Bamco New York has 0.71% invested in Masonite International Corp (NYSE:DOOR). 213,144 are held by Dimensional Fund Advsr Limited Partnership. Great Lakes Ltd holds 0.07% or 35,414 shares in its portfolio. Northern Tru reported 416,101 shares or 0.01% of all its holdings. Intl Grp holds 18,468 shares or 0% of its portfolio. Amer Century accumulated 178,873 shares.

Among 10 analysts covering Masonite International (NYSE:DOOR), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. Masonite International had 29 analyst reports since August 21, 2015 according to SRatingsIntel. Imperial Capital maintained the stock with “Outperform” rating in Friday, August 12 report. The company was maintained on Friday, August 11 by Robert W. Baird. Stifel Nicolaus maintained the stock with “Hold” rating in Thursday, November 9 report. The firm has “Outperform” rating given on Wednesday, July 6 by Imperial Capital. The stock of Masonite International Corp (NYSE:DOOR) has “Buy” rating given on Thursday, August 10 by Nomura. The stock of Masonite International Corp (NYSE:DOOR) earned “Hold” rating by TheStreet on Saturday, August 15. The firm has “Buy” rating given on Tuesday, August 8 by Stifel Nicolaus. On Monday, June 19 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock of Masonite International Corp (NYSE:DOOR) has “Outperform” rating given on Friday, June 16 by Wedbush. The firm has “Outperform” rating by Imperial Capital given on Friday, May 6.

Since May 26, 2017, it had 0 insider buys, and 1 sale for $413,985 activity. 5,500 shares were sold by Auerbach Gail N, worth $413,985.

Falcon Point Capital Llc increased Paratek Pharma (NASDAQ:PRTK) stake by 13,597 shares to 23,983 valued at $578,000 in 2017Q2. It also upped Cross Country Healthcare Inc (NASDAQ:CCRN) stake by 27,944 shares and now owns 112,536 shares. Neogenomics Inc. (NASDAQ:NEO) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>